Recombinant Mouse Interleukin Market to Grow at a CAGR of 6.5% Through 2032
According to a newly published market research report by 24LifeSciences, the global recombinant mouse interleukin market was valued at USD 117 million in 2024 and is projected to reach USD 180 million by 2031, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 20242031.
Download a Free Sample Report (PDF): https://www.24lifesciences.com..../download-sample/160
پسندیدن
اظهار نظر
اشتراک گذاری
